Abstract
Hemostasis is a major concern during the perioperative period. Changes in platelet aggregation and coagulation factors may contribute to the delicate balance between thrombosis and bleeding. We sought to better understand perioperative hemostasis by investigating the changes in platelet aggregation and coagulation factors during the perioperative period. We performed a prospective cohort analysis of 70 subjects undergoing non-emergent orthopedic surgery of the knee (n = 28), hip (n = 35), or spine (n = 7) between August 2011 and November 2011. Plasma was collected preoperatively (T1), 1-h intraoperatively (T2), 1-h (T3), 24-h (T4) and 48-h (T5) postoperatively. Platelet function testing was performed using whole blood impedance aggregometry. Coagulation assays were performed for factor VII, factor VIII, von Willebrand Factor (vWF), and fibrinogen. Of the 70 patients, mean age was 64.1 ± 9.8 years, 61 % were female, and 74 % were Caucasian. Platelet activity decreased until 1 h postoperatively and then significantly increased above baseline at 24- and 48-h postoperatively. Compared to baseline, coagulation factors decreased intraoperatively. Factor VII activity continued to decrease, while FVIII, vWF, and fibrinogen all increased above baseline postoperatively. The results of our study indicate significant changes in platelet activity and coagulation factors during the perioperative period. Both platelet activity and markers of coagulation decrease during the intraoperative period and then some increase postoperatively. These changes may contribute to the hypercoagulabity and/or bleeding risk that occurs in the perioperative period. Future prospective studies aimed at correlating hemostatic changes with perioperative outcomes are warranted.
Similar content being viewed by others
References
Oberweis BS, Nukala S, Rosenberg A, Guo Y, Stuchin S, Radford MJ, Berger JS (2013) Thrombotic and bleeding complications after orthopedic surgery. Am Heart J 165(3):427–433. doi:10.1016/j.ahj.2012.11.005
Chong CP, Lam QT, Ryan JE, Sinnappu RN, Lim WK (2009) Incidence of post-operative troponin I rises and 1-year mortality after emergency orthopaedic surgery in older patients. Age Ageing 38(2):168–174. doi:10.1093/ageing/afn231
Ausset S, Auroy Y, Lambert E, Vest P, Plotton C, Rigal S, Lenoir B, Benhamou D (2008) Cardiac troponin I release after hip surgery correlates with poor long-term cardiac outcome. Eur J Anaesthesiol 25(2):158–164. doi:10.1017/S0265021507001202
Jules-Elysee K, Urban MK, Urquhart B, Milman S (2001) Troponin I as a diagnostic marker of a perioperative myocardial infarction in the orthopedic population. J Clin Anesth 13(8):556–560
Lison S, Weiss G, Spannagl M, Heindl B (2011) Postoperative changes in procoagulant factors after major surgery. Blood Coagul Fibrinolysis 22(3):190–196. doi:10.1097/MBC.0b013e328343f7be
Cushman M (2007) Epidemiology and risk factors for venous thrombosis. Semin Hematol 44(2):62–69. doi:10.1053/j.seminhematol.2007.02.004
Mackman N (2008) Triggers, targets and treatments for thrombosis. Nature 451(7181):914–918. doi:10.1038/nature06797
Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C (2005) Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 353(22):2373–2383. doi:10.1056/NEJMra052717
Hermanides R, Ottervanger J, Elvan A, Ramdat Misier A (2009) Life-threatening perforation of a defibrillation lead. Neth Heart J 17(3):113–114
Mangano DT (1990) Perioperative cardiac morbidity. Anesthesiology 72(1):153–184
Mangano DT (1998) Adverse outcomes after surgery in the year 2001—a continuing odyssey. Anesthesiology 88(3):561–564
Mangano DT, Hollenberg M, Fegert G, Meyer ML, London MJ, Tubau JF, Krupski WC (1991) Perioperative myocardial ischemia in patients undergoing noncardiac surgery—I: incidence and severity during the 4 day perioperative period. The Study of Perioperative Ischemia (SPI) Research Group. J Am Coll Cardiol 17(4):843–850
Landesberg G, Mosseri M, Zahger D, Wolf Y, Perouansky M, Anner H, Drenger B, Hasin Y, Berlatzky Y, Weissman C (2001) Myocardial infarction after vascular surgery: the role of prolonged stress-induced, ST depression-type ischemia. J Am Coll Cardiol 37(7):1839–1845
Badner NH, Knill RL, Brown JE, Novick TV, Gelb AW (1998) Myocardial infarction after noncardiac surgery. Anesthesiology 88(3):572–578
Samama CM, Thiry D, Elalamy I, Diaby M, Guillosson JJ, Kieffer E, Coriat P (2001) Perioperative activation of hemostasis in vascular surgery patients. Anesthesiology 94(1):74–78
Gibbs NM, Crawford GP, Michalopoulos N (1992) Postoperative changes in coagulant and anticoagulant factors following abdominal aortic surgery. J Cardiothorac Vasc Anesth 6(6):680–685
Kobayashi S, Yokoyama Y, Matsushita T, Kainuma M, Ebata T, Igami T, Sugawara G, Takahashi Y, Nagino M (2012) Increased von Willebrand Factor to ADAMTS13 ratio as a predictor of thrombotic complications following a major hepatectomy. Arch Surg 147(10):909–917. doi:10.1001/archsurg.2012.998
Bezeaud A, Denninger MH, Dondero F, Saada V, Venisse L, Huisse MG, Belghiti J, Guillin MC (2007) Hypercoagulability after partial liver resection. Thromb Haemost 98(6):1252–1256
Toth O, Calatzis A, Penz S, Losonczy H, Siess W (2006) Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 96(6):781–788
Ausset S, Auroy Y, Verret C, Benhamou D, Vest P, Cirodde A, Lenoir B (2010) Quality of postoperative care after major orthopedic surgery is correlated with both long-term cardiovascular outcome and troponin IC elevation. Anesthesiology 113(3):529–540. doi:10.1097/ALN.0b013e3181eaacc4
Cram P, Lu X, Kates SL, Singh JA, Li Y, Wolf BR (2012) Total knee arthroplasty volume, utilization, and outcomes among medicare beneficiaries, 1991–2010. JAMA 308(12):1227–1236. doi:10.1001/2012.jama.11153
Esmon CT (2004) The impact of the inflammatory response on coagulation. Thromb Res 114(5–6):321–327. doi:10.1016/j.thromres.2004.06.028
D’Angelo A, Kluft C, Verheijen JH, Rijken DC, Mozzi E, Mannucci PM (1985) Fibrinolytic shut-down after surgery: impairment of the balance between tissue-type plasminogen activator and its specific inhibitor. Eur J Clin Invest 15(6):308–312
Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, Oswald E, Bach C, Schnapka-Koepf M, Innerhofer P (2007) Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 105(4):905–917. doi:10.1213/01.ane.0000280481.18570.27
Kageyama K, Nakajima Y, Shibasaki M, Hashimoto S, Mizobe T (2007) Increased platelet, leukocyte, and endothelial cell activity are associated with increased coagulability in patients after total knee arthroplasty. J Thromb Haemost 5(4):738–745. doi:10.1111/j.1538-7836.2007.02443.x
Gandhi SD, Weiskopf RB, Jungheinrich C, Koorn R, Miller D, Shangraw RE, Prough DS, Baus D, Bepperling F, Warltier DC (2007) Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch. Anesthesiology 106(6):1120–1127. doi:10.1097/01.anes.0000265422.07864.37
Innerhofer P, Fries D, Margreiter J, Klingler A, Kuhbacher G, Wachter B, Oswald E, Salner E, Frischhut B, Schobersberger W (2002) The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 95(4):858–865
Jungheinrich C, Sauermann W, Bepperling F, Vogt NH (2004) Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6 %) with an optimised in vivo molecular weight in orthopaedic surgery: a randomised, double-blind study. Drugs R D 5(1):1–9
Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P (2001) Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 92(4):855–862
Hermanides J, Huijgen R, Henny CP, Mohammad NH, Hoekstra JB, Levi MM, DeVries JH (2009) Hip surgery sequentially induces stress hyperglycaemia and activates coagulation. Neth J Med 67(6):226–229
Nygaard OP, Unneberg K, Reikeras O, Osterud B (1990) Thromboplastin activity of blood monocytes after total hip replacement. Scand J Clin Lab Invest 50(2):183–186. doi:10.1080/00365519009089151
Ravn HB, Hjortdal VE, Stenbog EV, Emmertsen K, Kromann O, Pedersen J, Sorensen KE (2001) Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection. Heart 85(1):61–65
Berger JS, Becker RC, Kuhn C, Helms MJ, Ortel TL, Williams R (2013) Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation. Thromb Haemost 109(1):85–92. doi:10.1160/TH12-03-0202
Trip MD, Cats VM, van Capelle FJ, Vreeken J (1990) Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 322(22):1549–1554. doi:10.1056/NEJM199005313222201
Pittens CA, Bouman HJ, van Werkum JW, ten Berg JM, Hackeng CM (2009) Comparison between hirudin and citrate in monitoring the inhibitory effects of P2Y12 receptor antagonists with different platelet function tests. J Thromb Haemost 7(11):1929–1932. doi:10.1111/j.1538-7836.2009.03585.x
Wallen NH, Ladjevardi M, Albert J, Broijersen A (1997) Influence of different anticoagulants on platelet aggregation in whole blood; a comparison between citrate, low molecular mass heparin and hirudin. Thromb Res 87(1):151–157
Acknowledgments
Data analysis and statistical support was provided by New York University School of Medicine Cardiovascular Outcomes Group. This study was funded by the New York Cardiac Center (JSB).
Conflict of interest
There are no conflicts of interest for any of the submitting authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Oberweis, B.S., Cuff, G., Rosenberg, A. et al. Platelet aggregation and coagulation factors in orthopedic surgery. J Thromb Thrombolysis 38, 430–438 (2014). https://doi.org/10.1007/s11239-014-1078-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-014-1078-1